Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The protocol is designed to determine the efficacy of temozolomide in preventing the
development of new brain metastases within the first year in patients undergoing stereotactic
radiation for newly diagnosed brain metastases.